Depression and Anxiety Trial, Recruiting NCT06757842 Sponsor: Universidad de los Andes, Chile Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06757842
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be an undergraduate student at the Universidad de los Andes.
  • You must be 18 years old or older.
  • You must be able to read and speak Spanish.
  • Your score on a standard depression questionnaire (called the PHQ-9) must be between 0 and 14, indicating no depression or mild-to-moderate symptoms.
  • You must have already attended an informational meeting explaining the study and what taking part involves.
  • You must be available to attend one 90-minute session per week for 8 weeks in a row, and be willing to practice mindfulness exercises at home for at least 15 minutes every day during the programme.

Who may not be able to join:

  • You may not be eligible if your PHQ-9 depression score is 15 or higher, suggesting more severe depression symptoms.
  • You may not be eligible if you are currently experiencing thoughts of suicide, as measured by a specific safety scale used by the study team (confirm with trial site).
  • You may not be eligible if you are currently receiving psychiatric treatment for a serious condition such as a psychotic disorder or substance misuse.
  • You may not be eligible if you have been hospitalised for a psychiatric condition at any point in the last 2 years.
  • You may not be eligible if you have previously completed a mindfulness-based programme or course, such as MBCT, MBSR, or similar (confirm with trial site for specific examples).
  • You may not be eligible if you have a history of sexual abuse at any point in your life.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +56226181000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad de los Andes, Chile
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Acceptability Assessment; Feasibility Assessment: Number of participants recruited; Feasibility Assessment: Recruitment time for completion; Feasibility Assessment: Evaluation of data collection and results.; Feasibility Assessment: Evaluation of the acceptability of the intervention; Client Satisfaction Questionnaire (CSQ-8)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov